News & Events


May 7, 2019

ALCOR Scientific Prevails in Patent Infringement Case – Press Release

miniiSED ESR Analyzer logo Coming Soon!!!

Smithfield, R.I. – April 29, 2019 – ALCOR Scientific introduces the miniiSED™ as the newest addition to the iSED® family of Erythrocyte Sedimentation Rate (ESR) analyzers from ALCOR Scientific. The miniiSED™ measurement of ESR is fast, accurate and unaffected by the many variables known to be associated with traditional methodologies, such as hematocrit. This single position, fully automated ESR analyzer works directly from primary EDTA tubes or BD Microtainer® MAP Microtubes, requires just 100 microliters of sample, is equipped with an internal barcode reader, and produces a result in just under 15 seconds! The miniiSED™ small footprint combined with its advanced design and rapid time to result makes it the ideal solution to ESR testing for small laboratories, POL’s, and emergency clinics. The miniiSED™ is proudly manufactured in the USA.

ALCOR Scientific’s iSED Selected for Use at the 2018 Winter Olympics.

Smithfield, R.I. – February 6, 2018 – ALCOR Scientific, a Rhode Island based manufacturer, proudly announces that the iSED Analyzer will be used by the laboratory at the Pyeongchang 2018 Olympic Winter Games and Paralympic Winter Games Medical Center.

Read More >

ALCOR Scientific is First Rhode Island Company to do Business in Iran, Post-Sanctions

ALCOR makes inroads into the Iranian healthcare market with the iSED – a highly accurate blood analyzer that allows laboratories to identify inflammation in patients in just 20 seconds

Smithfield, R.I. – August 4, 2016 – ALCOR Scientific today announced that it is the first Rhode Island-based company to do business in Iran in 15 years, following the lifting of international trade sanctions in January. With U.S.-Iran trade relations now open, ALCOR will be selling its iSED® Erythrocyte Sedimentation Rate Analyzer – a blood analyzer that identifies inflammation in patients – to Iranian hospitals and laboratories.

Read More >